Introduction
► A recent study found that globally over 50% of patients in the general population are not adherent to their prescription medication, and poor adherence was associated with higher economic costs, greater hospitalization and mortality. 1 ► Reducing out-of-pocket costs can increase medication adherence, which in turn impacts long-term health outcomes. 2 ► Likewise, reducing out-of-pocket costs has been associated with fewer emergency room visits, hospitalizations, and prescription costs in patients with hypertension. 3 ► Hypertension patients in Russia have been found to be non-adherent to their hypertension treatment. 4 ► The impact of cost-cutting strategies on outcomes in hypertension patients has not been assessed among Russian patients.
Objectives
► To determine loss of health status, work productivity impairment, and activity impairment associated with non-adherent prescription cost-cutting in Russian hypertension patients.
Methods
Study Design ► Data were obtained from the 2011 Russia National Health and Wellness Survey (NHWS). ► The Russia NHWS is an annual cross-sectional, self-administered survey assessing demographics, health status, health related attitudes, disease status, and outcomes developed and managed by Kantar Health. ► The survey sample is drawn from an Internet panel maintained by Lightspeed Research and its partners, and supplemented by offline recruitment. ► A stratified random sampling framework was applied to ensure the NHWS sample is identical to the Russian urban adult population with respect to age and gender. ► The sample includes 10,039 adults (18+) in Russian cities.
Sample
► Respondents of the 2011 Russia NHWS who reported being diagnosed with hypertension and taking a prescription medication for hypertension were included in the analyses.
Study Measures
► Non-adherent cost-cutting behaviors were defined as: ■ Taking less medication than prescribed ■ Cutting tablets in half ■ Buying fewer tablets ■ Not buying prescriptions recommended by the physician ■ Buying a less expensive alternative instead ■ Buying prescriptions less often ► Adherent behaviors included: ■ Asking physician/pharmacist for cheaper alternatives ■ Using a discount card ► Demographics, health history, co-morbidities, and cost-cutting behaviors were assessed for all respondents. ► Health-related quality of life was assessed using the SF-12v2. Mental component summary (MCS) and physical component summary (PCS) scores were calculated as were SF-6D health state utilities. ► Absenteeism, presenteeism, overall work impairment and activity impairment were measured using the Work Productivity and Activity Impairment (WPAI) questionnaire.
Statistical Analysis
► Patient demographics and health history were analyzed descriptively across the sample and also compared between those engaging in adherent, non-adherent cost-cutting and no cost-cutting behaviors using chi-square tests for categorical variables and ANOVAs for continuous variables. ► Use of non-adherent cost-cutting strategies was entered into a series of multiple regression models to quantify the burden associated with non-adherent vs. all others (adherence cost cutting + no cost-cutting grouped together) on health status and WPAI metrics, controlling for demographics (age, gender, education, household income, and health insurance) and patient characteristics (weight, BMI level and the Charlson Comorbidity Index). ► Linear regression models were used to predict health-related quality of life (MCS, PCS, and health state utilities) while generalized linear models with a negative binomial distribution predicted the work productivity measures.
Results
► Out of 1,712 diagnosed hypertension patients taking prescription medication for hypertension, 34.3% reported no cost-cutting behaviors, 28.2% reported using only adherent cost-cutting behaviors, and 37.5% reported using non-adherent cost-cutting behaviors (see Figure 1 ).
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Conclusions
► Over a third of hypertension patients cut costs using strategies that interfere with medication adherence. ► After adjusting for demographics and comorbidities, these patients have lower health status than patients who avoid cost-cutting or cut costs in ways that do not interfere with medication adherence. ► The presence of non-adherent cost-cutting behaviors was also associated with greater work productivity loss (34% more work time lost) even after adjusting for covariates. ► These patients practicing non-adherent cost-cutting strategies should be identified and guided to improve adherence or adherent cost-sharing to their prescription medications to facilitate better health outcomes.
Limitations
► The survey sample may not be representative of the total Russian hypertensive population. ► The cross-sectional design of the survey prevents causal inferences between cost-cutting and health outcomes.
► Assessment of cost-cutting strategies was not limited to hypertension medications, so results may be due to use of strategies with medications taken for co-morbid conditions. ► All collected data were self-reported and no clinical verification of hypertension, prescription medication use, or cost-cutting behaviors were available.
Results (continued)
► Compared to adherent and non cost-cutters, bivariate analysis of demographic characteristics, health history and comorbidities showed that the non-adherent group: ■ Had a larger proportion of females than males ■ Were younger in age ■ Had an equivalent proportion of respondents with a college education ■ A lower proportion of employed respondents ■ A greater percentage of insured patients ■ A higher percentage of respondents the use alcohol and people who currently exercise ■ Had similar comorbidity burden as the other two groups 
